Goldman Sachs
DRTS icon

Goldman Sachs’s Alpha Tau Medical DRTS Stock Holding History

Goldman Sachs’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$185K Buy
+26,189
New +$185K ﹤0.01% 6106
2025
Q4 		– Sell
-12,315
Closed -$55.5K – 6522
2025
Q3 		$55.5K Buy
+12,315
New +$41.9K ﹤0.01% 6163

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Goldman Sachs's DRTS Position: Q1 2026 in Review

Goldman Sachs opened a new position in Alpha Tau Medical (DRTS) in Q1 2026: 26,189 shares worth $185K. The stake represents ﹤0.01% of the portfolio and ranks #6106 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in DRTS as recently as Q3 2025.

Goldman Sachs first reported a position in DRTS in Q3 2025 and has held it in 2 quarters since. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • Goldman Sachs held 26,189 shares of Alpha Tau Medical worth $185K as of Q1 2026.
  • Alpha Tau Medical was a new Goldman Sachs position in Q1 2026.
  • Alpha Tau Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6106 holding.
  • Goldman Sachs first reported a position in Alpha Tau Medical in Q3 2025 and has held it in 2 quarters since.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.